Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
we decrease » _ decrease (Expand Search), teer decrease (Expand Search), use decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
681
-
682
-
683
-
684
-
685
Spatial training decreases the association between Ndfip1 and Nedd4 and decreases endogenous Beclin 1 ubiquitination in the hippocampus.
Published 2023“…The Ndfip1 expression level is decreased in both the IP product and the lysate in trained rats. …”
-
686
-
687
-
688
-
689
-
690
-
691
-
692
-
693
-
694
Rhinorrhea-free days up to day 10.
Published 2024“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”
-
695
Vomit-free days up to day 10.
Published 2024“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”
-
696
Symptoms free-days up to day 10.
Published 2024“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”
-
697
Diarrhea-free days up to day 10.
Published 2024“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”
-
698
Nausea-free days up to day 10.
Published 2024“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”
-
699
Cough-free days up to day 10.
Published 2024“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”
-
700
Dyspnea-free days up to day 10.
Published 2024“…Patients were randomized in a 1:1:1 ratio to receive halofuginone 0.5mg, 1mg or placebo orally once daily for 10 days. …”